use | brompiridine is an aryl pyrimidine anti-metabolic anti-tumor drug, a bladder cancer chemotherapy drug jointly developed by the United States and Japan. |
biological activity | Bropirimine is a synthetic agonist of toll-like receptor 7 (TLR7). Bropirimine the production of IFN-β mediated by TLR7 inhibits the differentiation of osteoclast precursor cells into osteoclasts. Bropirimine is an orally active immunomodulator with anticancer activity in orthotopic transitional cell carcinoma (CIS) of the bladder and upper urinary tract. |
category | toxic substances |
toxicity classification | poisoning |
acute toxicity | oral-rat LD50:>3200 mg/kg |
flammability hazard characteristics | combustible; combustion produces toxic nitrogen oxides and bromide smoke |
storage and transportation characteristics | warehouse ventilation and low temperature drying |
fire extinguishing agent | dry powder, foam, sand, carbon dioxide, mist water |